Latest News

Dr Freda Lewis-Hall, well-known in the US for her television appearances, spoke to PharmaDIspatch about the experience and the impact on perceptions of the pharmaceutical industry.

A new dispute between industry and the government this time over a fee waiver for medicines covered by an orphan designation.

CSL (ASX:CSL) has reported net profit after tax of $1.729 billion for the twelve months ended 30 June 2018, an increase of 29 percent on the previous year, a result "slightly ahead" of the most recent guidance.

Sydney-based Pharmaxis (ASX:PXS) has received approval from the US FDA for its manufacturing facility to produce the asthma diagnostic product Aridol for the US market. The company said the...

It is hard to imagine officials in the Department of Finance and maybe even the Department of Health ever thought the push for rebate reform might finally provide the evidence they have sought for ten years to prove some are engaged in the systematic monetisation of vial sharing.

Allergan Australia has launched a new device to manage what it describes as the world’s leading cause of irreversible blindness - XEN Glaucoma Gel Implant.

A new survey of Australian oncologists has found over 3,500 people are spending a combined $200 million every year, or around $60,000 each, to finance access to unsubsidised medicines.

The Society of Hospital Pharmacists of Australia has responded to questions from PharmaDispatch about vial sharing.

Most Australians believe pharmacists should be able to administer common vaccinations that are currently only administered by doctors, according to new research released by the PSA.

AbbVie Ventures, Brandon Capital’s Medical Research Commercialisation Fund (MRCF) and OneVentures have announced a $6 million investment into new biotechnology company Paragen Bio.

Merck has announced the appointment of an experienced pharmaceutical company executive as the managing director of its Australia and New Zealand biopharma business.

In an exclusive interview, the new leadership team for Medicines Australia Dr Anna Lavelle and Liz de Somer say they are about setting up the organisation for success.